Minomic executes agreement with Cirrus Dx

Australia |  News | 0 Comment | 19 Feb, 2019

Australia based diagnostic company, Minomic International Ltd has announced that the company has executed an agreement with US based pathology laboratory, Cirrus Dx. The agreement allows C...Read more

Invitrocue appoints Prof Arial Zeng Yi as Patient Derived Organoid Consultant

Australia |  News | 0 Comment | 18 Feb, 2019

Invitrocue, a leading healthcare bio-analytic solutions provider, is pleased to announce the appointment of Professor Arial Zeng Yi as Patient Derived Organoid (PDO) Consultant. Professor Z...Read more

Mayne Pharma launches anti-plaque psoriasis agent in US

Australia |  News | 0 Comment | 14 Feb, 2019

Mayne Pharma Group Limited has announced the launch of LEXETTE™ (halobetasol propionate) Foam 0.05% in the United States. LEXETTE, the conditionally-acceptable trade name for halobet...Read more

Cartherics and panCELLa announce collaborative agreement for cell therapy

Australia |  News | 0 Comment | 15 Feb, 2019

Cartherics and panCELLa have announced their collaboration to research, develop and commercialize products for the treatment of cancer and other debilitating diseases using cell therapy. P...Read more

SpeeDx submits RespiVirus assay for clinical approval

Australia |  News | 0 Comment | 13 Feb, 2019

SpeeDx Pty. Ltd. has announced submission of their PlexPCR® RespiVirus test to the Therapeutic Goods Administration (TGA). The company anticipates clearance in time for the Australian 2...Read more

Invitrocue creates Joint Venture with A*STAR scientist Dr Chen Qingfeng

Australia |  News | 0 Comment | 12 Feb, 2019

Invitrocue, a leading healthcare bio-analytic solutions provider, is pleased to announce the establishment of InvivoCue, a joint venture (JV) between Invitrocue and A*STAR scientist Dr. Che...Read more

“An efficient approach to clinical trial design will have the greatest impact”

Australia |  Opinion | 0 Comment | 06 Feb, 2019

The annual J.P. Morgan Healthcare Conference is the premier investor conference focused exclusively on companies defining the healthcare industry. This is the largest and most informative h...Read more

Strides to exit investment in Arrow

Australia |  News | 0 Comment | 04 Feb, 2019

Strides Pharma Science Limited (Strides) has announced that its step-down subsidiary Strides Pharma Global Pte, Limited, has approved the sale of its entire Australian business (Including A...Read more

The iQ Group Global launches saliva glucose biosensor

Australia |  News | 0 Comment | 01 Feb, 2019

The iQ Group Global, a consortium of life science and financial services companies which span the biopharma value chain from asset discovery to commercialization, has introduced the Saliva ...Read more

Mayne Pharma launches Tolsura capsules in the US

Australia |  News | 0 Comment | 30 Jan, 2019

Australia-based Mayne Pharma is pleased to announce the launch of TOLSURA (SUBA®-itraconazole) 65mg capsule in the United States. TOLSURA is a new formulation of itraconazole indicated ...Read more

Resistance-guided therapy for Gonorrhoea now available

Australia |  News | 0 Comment | 25 Jan, 2019

UK patients with N. gonorrhoeae (GC) now have the option of receiving the cheap and easily-administered oral antibiotic ciprofloxacin thanks to updated treatment guidelines a...Read more

Novel device to diagnose and treat patients much faster

Australia |  News | 0 Comment | 23 Jan, 2019

Scientists from Monash University have developed a new device that can rapidly screen the blood in just minutes to detect a range of pathogens that cause disease, in a breakthrough that cou...Read more

Invitrocue declares changes in board

Australia |  News | 0 Comment | 09 Jan, 2019

Invitrocue Limited, a leading healthcare bio-analytic solutions provider, announces the appointment of Dr. Steven Fang as Chairman of the Company’s Board of Directors with immediate e...Read more

Immutep collaborates with CYTLIMIC

Australia |  News | 0 Comment | 08 Jan, 2019

Immutep Limited has announced that it has entered into a clinical trial collaboration agreement, a supply agreement and a service agreement with CYTLIMIC Inc.  for its lead product can...Read more

Scientists discover a molecule that predicts patient's ability to survive melanoma

Australia |  News | 0 Comment | 02 Jan, 2019

Doctors may be able to assess the survival rates of melanoma patients following the discovery of a molecule that allows the cancer to spread from the skin to other parts of the body. Unive...Read more

Patrys’s drug suppresses breast cancer brain metastases, increases survival

Australia |  News | 0 Comment | 24 Dec, 2018

Singapore -  Patrys Limited, a therapeutic antibody development company, is pleased to announce further pre-clinical data for its drug candidate PAT-DX1, Patrys’ humanized versio...Read more

Australian researchers to start clinical trials for dementia ultrasound treatment

Australia |  News | 0 Comment | 20 Dec, 2018

Safety testing of a pioneering ultrasound technique that could delay the effects of dementia will begin in Brisbane late next year, led by University of Queensland researchers. Federal Min...Read more

NeuClone discloses its sixth biosimilar candidate of Pertuzumab

Australia |  News | 0 Comment | 18 Dec, 2018

NeuClone Pharmaceuticals Ltd. (NeuClone), a clinical-stage biopharmaceutical company exclusively focused on developing high-quality biosimilar products has disclosed the sixth biosimilar be...Read more